| For: | Huang JH, Guo W, Liu Z. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World J Gastroenterol 2023; 29(3): 579-581 [PMID: 36688025 DOI: 10.3748/wjg.v29.i3.579] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i3/579.htm |
| Number | Citing Articles |
| 1 |
Xuelong Wang, Yizhi Cao, Jiangning Gu, Tuoya Qi, Jiayi Guo, Yuanjie Yang, Haoyu Tang, Tianci Shen, Qingzhong Wang, Xin Cao, Kai Qin, Jiabin Jin. 3D epigenomic remodelling mediated by Foxa1 drives gemcitabine resistance in pancreatic cancer. Cancer Letters 2026; 658 doi: 10.1016/j.canlet.2026.218721
|
| 2 |
Ke Ye, Shuhua Zhou, Xuejun Gong, Zhongcheng Zhu, Moyan Xiao, Shuai Liang. TGM2-P2RX7 loop promotes gemcitabine resistance in pancreatic cancer by modulating glutamine metabolism and mitophagy. Cell Death Discovery 2025; 12(1) doi: 10.1038/s41420-025-02922-x
|
| 3 |
Boqiang Liao, Junqi Huang, Honghai Chen, Feng Xia, Pengfei Guo, Ge Song, Jianghua Feng, Guiping Shen. Enhanced predictive accuracy of pancreatic ductal adenocarcinoma staging: A synergistic approach merging machine learning algorithms with metabolic profiling. Chemometrics and Intelligent Laboratory Systems 2025; 265 doi: 10.1016/j.chemolab.2025.105497
|
| 4 |
Jinnuo Lu, Yixiao Huang, Shujie Ma, Shoucheng Hu, Linhua Xuzhan, Yifan Huang, Bowen Wu, Zekai Hu, Chenyou Zhao, Jiayi Huang, Baoao Tan, Xinhao Liu, Zhaobin Guo. A microfluidic lung cancer-vascular tumor-on-a-chip model for precise evaluation of anti-invasion therapeutics. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-026-02185-5
|
| 5 |
Haocheng Yin, Zeyu Zhang, Yapeng Liu, Yutian Wang, Hui Guo, Yuming Zhang. A SiC Photo-Conductive Switch-Based Pulse Generator with Nanoseconds and High Voltage for Liver Cancer Cells Ablation Therapy. Electronics 2024; 13(23) doi: 10.3390/electronics13234816
|
| 6 |
Mohini Singh, Niva Rani Gogoi, Bani K. Jana, Tumpa Sarkar, Venessa Nath, Bhaskar Mazumder. Drug Delivery Landscape in Cancer Research. 2025; doi: 10.1016/B978-0-443-29168-5.00002-7
|
| 7 |
RenZhe Tang, XiaoQing You. LncRNA ROR1‐AS1 Stimulates Epithelial‐Mesenchymal Transition and Chemoresistance of Pancreatic Cancer by Upregulating HMGB1 Through miR‐33a‐5p Adsorption. Journal of Biochemical and Molecular Toxicology 2025; 39(9) doi: 10.1002/jbt.70499
|
| 8 |
Masoumeh Mohammadi, Amir Abbas Rafati, Ahmad Bagheri. A Sensitive Electrochemical DNA Biosensor for Determination of Anti-Cancer Drug Gemcitabine Based on an AuNPs/MWCNTs/Carbon Paste Electrode. Journal of The Electrochemical Society 2023; 170(11) doi: 10.1149/1945-7111/ad0baa
|
| 9 |
Dohee Ahn, Hong Kyu Lee, Sang Hyeok Bae, Hwayoung Na, Kyung-Chul Choi. Downregulation of transforming growth factor-β2 enhances the chemosensitivity to gemcitabine with diminished metastasis in pancreatic cancers. Biomedicine & Pharmacotherapy 2025; 188 doi: 10.1016/j.biopha.2025.118151
|
| 10 |
Zhuo Zhong, Jian Yang, Jing-Zi Luo, Xiong Xie, Zhi-Mei Huang, De Long. Efficacy of continuous arterial perfusion chemotherapy combined with transarterial chemoembolization regional arterial thermal perfusion in the treatment of pancreatic cancer with liver metastases. Oncology and Translational Medicine 2023; doi: 10.1097/ot9.0000000000000001
|
| 11 |
Richard Daifuku, Yu Zhang, Jingjing Wang, Qingyang Gu. iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer. Translational Medicine Communications 2024; 9(1) doi: 10.1186/s41231-024-00161-3
|
| 12 |
Brahmi Shenoy, Miloni Mandani, Meena Chintamaneni, Sonal M. Manohar. Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit. Current Issues in Molecular Biology 2025; 47(9) doi: 10.3390/cimb47090775
|